Navigation Links
Anna Balazs announced as 2013 Mines Medalist
Date:1/29/2013

m of systems, including nanocomposites, self-oscillating gels, self-healing materials and polymeric microcapsules.

Dr. Balazs' work focuses on developing theoretical and computational models to capture the behavior of polymer blends, nanocomposites, complex fluids and colloidal systems, work that is "crucial to develop predictive models for the behavior" of designing advanced materials, according to one of her nominators Steven R. Little, Ph.D., chair of the Department of Chemical and Petroleum Engineering at the University of Pittsburgh.

"It is in this area that Balazs and her research group have made fundamentally important and unique contributions, which are allowing scientists to understand how choices made at the molecular level affect the macroscopic performance of the system." Little described her work as both "theoretically elegant and applicable to real materials of industrial relevance."

She has been a fellow in the Royal Society of Chemistry; a senior visiting fellow at Oxford Center for Advanced Materials and Composites and Materials Science Department (Oxford University); visiting fellow at Corpus Christi College, Oxford University; and a fellow with the American Physical Society.

Her work has been published in Science, Nature and numerous other publications and has been described in popular media outlets such as The Economist and Science News.

She will be presented the next Mines Medal during the Oct. 3, 2013, Mines Medal Dinner and Award Ceremony to be held at the Rushmore Plaza Civic Center.

Dr. Balazs says she feels "extremely honored to be inducted into a group that includes such illustrious awardees."

Previous Medalists include Dr. Diana Wall, 2012 recipient and University Distinguished Professor and director of the School of Global Environmental Sustainability at Colorado State University; Dr. Lee Rybeck Lynd, 2011 recipient and professor of engineering a
'/>"/>

Contact: Fran LeFort
Fran.LeFort@sdsmt.edu
605-394-6082
South Dakota School of Mines and Technology
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Young Investigator Award winners announced by Anatomy Society
2. MARC travel awards announced for the 2012 ISCB Rocky Mountain Bioinformatics Conference
3. Finalists of air pollution sensor challenge announced
4. Global metabolomic initiative announced
5. Marc Travel Awards announced for the 2012 Biomedical Engineering Society Annual Meeting
6. MARC travel awards announced for 2012 American Society for Bone & Mineral Research annual meeting
7. MARC travel awards announced for the 2012 APS Integrative Biology of Exercise meeting
8. MARC travel awards announced for the 2012 SACNAS Annual Meeting
9. 2013 Rosalind Franklin Young Investigator Awards announced
10. 2012 Reed Elsevier Environmental Challenge winners announced
11. 2012 Science in Society Journalism Awards announced
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Anna Balazs announced as 2013 Mines Medalist
(Date:7/28/2014)... DUBLIN , July 28, 2014 ... the "Biometrics Market in Latin America 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 Biometrics measure and analyze biological ... facial patterns, irises, eye retinas, voice patterns, and hand ... one or more stored templates. The main purpose of ...
(Date:7/28/2014)... became the first man to reach the South Pole ... an international team of scientists led by Joe McConnell ... air pollution from industrial activities arrived long before. , ... spaced locations around the Antarctic continent, including the South ... reconstruction to date of lead pollution over the Earth,s ...
(Date:7/27/2014)... DURHAM, N.C. -- Microorganisms like bacteria and fungi can ... by antibiotics or antifungal drugs. These permanent mutations were ... strains to evolve. Now a new study has shown ... targets -- known as epimutations -- to gain the ... the new mechanism was discovered in a fungus called ...
Breaking Biology News(10 mins):Biometrics Market in Latin America 2014-2018 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 2Industrial lead pollution beat explorers to the South Pole by 22 years and persists today 3Scientists discover new, noncommittal mechanism of drug resistance 2Scientists discover new, noncommittal mechanism of drug resistance 3
... of evolution is periodically marked by explosions in biodiversity, ... of shapes and sizes. With a new analysis of ... have discovered that these diversifications proceeded head-first. By ... around the time of two separate extinction events, scientists ...
... are fascinating plant organs they not only anchor the ... Roots live in darkness and direct the activities of the ... Charles Darwin posited in The Power of Movement of Plants ... Due to the difficulty of accessing root tissue in ...
... Mediterranean diet with large amounts of vegetables and fish gives ... studies to be published by the Sahlgrenska Academy at the ... shown that a Mediterranean diet, based on a high consumption ... products such as meat and milk, leads to better health., ...
Cached Biology News:'Head-first' diversity shown to drive vertebrate evolution 2'Head-first' diversity shown to drive vertebrate evolution 3New tool offers unprecedented access for root studies 2
(Date:7/28/2014)... 28, 2014  InterMune, Inc. (NASDAQ: ITMN ... quarter 2014 financial results at the close of the ... call and webcast will be hosted by InterMune at ... Interested investors and others may participate in the conference ... conference ID#21728775. A replay of the webcast and teleconference will ...
(Date:7/25/2014)... Albany, NY (PRWEB) July 26, 2014 ... Trials Review, H2, 2014" provides data on the ... This report provides elemental information and data relating ... Cerebral Stroke. , View full global Ischemic Stroke ... It includes an overview of the trial numbers ...
(Date:7/25/2014)... July 25, 2014 According to a ... Drugs Market - Global Industry Analysis, Size, Share, Growth, ... drugs market is estimated at USD 161,056.5 million in ... of 10.1% from 2014 to 2020, to reach an ... The biological drugs market is witnessing a significant growth ...
(Date:7/25/2014)... /PRNewswire-iReach/ -- Xybion Corporation, the leading provider of ... in highly regulated industries, announced today that the ... Group Conference, Xybion International Exchange, on October 21-23, ... at the Sheraton Society Hill Hotel.  ... This year,s conference theme is Compliance Fusion.  ...
Breaking Biology Technology:InterMune to Release Second Quarter Financial Results on August 6 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 2Ischemic Stroke and Cerebral Stroke Global Clinical Trials Review H2, 2014: MarketResearchReports.Biz 3Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 2Biological Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020 3Xybion Announces It Will Host International User Conference in Philadelphia 2Xybion Announces It Will Host International User Conference in Philadelphia 3
... leaders, experts and foreign ministry delegations set to be involved in ... ... Singapore (PRWEB) March 2, 2009 -- Asia-Pacific,s largest and most ... Asia 2009 (GSA 2009), will be held in Singapore from 17th ...
... LOUIS, Feb. 27 A copy of the Company,s December ... Exchange Commission, may be obtained without charge at our website ... Sigma-Aldrich Corporation, P. O. Box 14508, St. Louis, Missouri 63178. ... Life Science and High Technology ...
... CV Therapeutics, Inc. (Nasdaq: CVTX ) today ... time in response to Astellas Pharma Inc.,s announcement that ... unsolicited tender offer for all outstanding common shares of ... in cash. CV Therapeutics, board of directors, in ...
Cached Biology Technology:News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009 2News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009 3CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 2CV Therapeutics Advises Stockholders to Take No Action at This Time in Response to Astellas' Tender Offer 3
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Purified anti-LAT...
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Purified anti-human CD182 (CXCR2)...
Biology Products: